Form 4: Alignment Healthcare's Chief Medical Officer Reports Stock Transactions Following PSU Vesting

Hyong Kim, Chief Medical Officer of Alignment Healthcare, reports the acquisition and disposal of common stock following the vesting of performance share units (PSUs).

Summary

• On March 4, 2025, Hyong Kim, the Chief Medical Officer of Alignment Healthcare, acquired 58,400 shares of common stock related to the vesting of performance share units (PSUs).
• These PSUs were granted on September 14, 2023, and vested based on the achievement of certain performance objectives, including health plan revenue growth, at-risk returning member medical benefit ratio, and adjusted EBITDA less capital expenditures.
• The performance objectives were achieved above target.
• 50% of the granted PSUs vested on March 4, 2025, and the remaining 50% will vest on December 31, 2025, contingent upon continued service.
• On March 5, 2025, Kim sold 13,394 shares at a weighted-average price of $15.7189 per share.
• On March 6, 2025, Kim sold 7,626 shares at a weighted-average price of $15.53 per share to cover tax withholding obligations related to the PSU vesting.
• Following these transactions, Kim beneficially owns 507,876 shares of Alignment Healthcare common stock.

Sentiment

Score: 7

Explanation: The document is neutral to slightly positive. The vesting of PSUs suggests the company met its performance targets. The stock sales are routine and expected.

Positives

• The vesting of PSUs indicates that Alignment Healthcare achieved its performance objectives above target.
• Hyong Kim's continued holding of a significant number of shares (507,876) suggests confidence in the company's future.

Negatives

• The sale of shares to cover tax obligations, while standard, could be perceived negatively by some investors.

Risks

• Future vesting of the remaining 50% of PSUs is contingent upon Kim's continued service to the company.
• Fluctuations in the stock price could impact the value of Kim's holdings and potentially influence future trading decisions.

Future Outlook

Fifty percent of the granted PSUs will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date.

Industry Context

Executive stock transactions are common in publicly traded companies and are often tied to performance-based compensation plans. The vesting of PSUs indicates that the company has met certain performance targets, which is generally viewed positively.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards like PSUs to align management's interests with those of shareholders.
• Vesting schedules and performance metrics vary across companies and industries, but revenue growth, profitability, and cost management are common factors.
• Comparing Alignment Healthcare's PSU metrics to those of its peers, such as Humana, UnitedHealth Group, or CVS Health (Aetna), would provide a better understanding of the company's performance relative to industry benchmarks.

Stakeholder Impact

• Shareholders may view the PSU vesting as a positive sign of company performance.
• Employees may be motivated by the achievement of performance targets and the potential for future equity awards.

Key Dates